GLP-1 RAs constitute a promising option for NAFLD with T2D since they can induce considerable weight loss, decrease visceral adipose tissue (VAT), and improve insulin sensitivity [8,37]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.